Sponsored Content

Rousselot to showcase Nextida® collagen peptides with science on glucose control and GLP-1 at Vitafoods Europe 2025

Rousselot, booth 3K119, Vitafoods Europe, 20 - 22 May 2025, Barcelona, Spain 

Irving, Texas, US, 15 April – Rousselot, Darling Ingredients’ premier collagen and gelatin brand, introduces Nextida GC at Vitafoods Europe, following its successful U.S. launch in 2024. Nextida GC is a specific collagen peptide composition targeting glucose control and GLP-1.

“As consumer awareness of glucose management and GLP-1¹ increases, we are excited to present Nextida GC with new clinical data in Barcelona,” said Florencia Moreno Torres, Global Business Development Manager for Health & Nutrition at Rousselot. “Nextida GC offers a unique approach in the nutraceutical space to help brands address the evolving metabolic health market, the natural way.”

Nextida GC, the first ingredient from Rousselot’s Nextida platform of specific collagen compositions, is designed to maintain balanced post-meals glucose levels in healthy individuals by leveraging the body’s natural GLP-1 response.² In pre-clinical and clinical studies,³ Nextida GC demonstrated its ability to enhance the body’s glucose regulation mechanism. Glucose control is important to avoid destabilizing sugar crashes and potentially their associated consequences such as cravings, overeating and fatigue.⁴

Visitors at Rousselot booth will have an opportunity to taste Nextida GC application prototypes and gather first-hand insights in two expert-led sessions at the New Ingredients Theatre (3G266):

-GLP-1 Nutrition, the key upcoming category in the nutraceutical world – by Florencia Moreno Torres, Global Business Development Manager Health & Nutrition at Rousselot, May​ 20 at 14:30-14:55​ CEST

-Nextida GC: the science behind boosting natural GLP-1 with collagen – by Dr. Catarina Ferreira da Silva, Science Integration Manager at Rousselot, May 21 at 14:30-14:55​ CEST

Beyond innovative solutions for glucose control, Rousselot will present its extensive collagen portfolio, including Peptan^®, the premium collagen peptides for holistic health, shown in studies to support skin⁵ and hair⁶ beauty, mobility,^7,8  sports recovery⁹ and sleep¹⁰ and Colartix^®, a unique matrix of collagen peptides and chondroitin sulfate with science on joint care.¹¹

The company’s proprietary gelatin solutions will also be on display, fostering innovation and performance in functional gummies, softgels, and hard capsules. Additionally, visitors will have the opportunity to learn more about Rousselot's globally produced pharmaceutical gelatins, designed to meet high-quality standards and ensure reliable supply, supported by Rousselot’s formulation and regulatory expertise.

To be among the first in Europe to explore Nextida GC, and to discover the wider collagen and gelatin portfolio, visit booth 3K119. 

For more information, visit Rousselot.com

Rousselot makes no representation or warranty, whether expressed or implied, as to the accuracy, reliability, or completeness of the information, nor does it assume any legal liability, whether direct or indirect, for any information. Use of this information shall be at your discretion and risk. Nothing herein relieves you from carrying out your own suitability determinations and tests and from your obligation to comply with all applicable laws and regulations and to observe all third-party rights. This product is not intended to diagnose, treat, cure, or prevent any disease.